Bioabsorbable Stents Market - Global Forecast to 2021

The global bioabsorbable stents market is expected to reach USD 2.4 billion by 2021 from USD 0.4 billion by 2016, at a CAGR of 42.5% during the forecast period. The major driving factors are the increasing focus of the companies on clinical trials of bioabsorbable stents, increasing aging population, technological advancements, and patients’ preference for minimally invasive therapies. However, factors such as the high prices of these stents may hamper the growth of the market.
Europe is the largest regional market for bioabsorbable stents, accounting for 60% of the total market in 2016. The North American market is expected to grow at the highest CAGR of 46.1% during the forecast period, due to the increase in aging population, unhealthy lifestyle habits, and the strong healthcare infrastructure in this market.
Traditionally, bare metal stents were used for the treatment of coronary and peripheral artery diseases. Due to various complications, such as stent thrombosis and the increased risk of restenosis, these stents were replaced by drug-eluting stents, which in turn were succeeded by bioabsorbable stents. Bioabsorbable stents have overcome the complexities and disadvantages of drug-eluting stents. They restore the normal ability of the artery to contract & relax, improve abnormal endothelial function, and permit remodeling of the vessel.
Apart from the comprehensive regional analysis, and market sizing, the report also provides a competitive landscape that covers growth strategies adopted by industry players over the last three years. The company profiles comprise basic views on key players and their product portfolios, developments, and strategies adopted. The above-mentioned market research data, current market sizes, and forecast of future trends will help key players and new entrants make informed decisions regarding product offerings, geographical focus, change in strategic approach, R&D investments, and levels of output in order to remain successful.
Reasons to Buy the Report:
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms, garner a greater market share. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.
The report provides insights on the following pointers:
‧ Market Penetration: Comprehensive information on the product portfolios of the top players in the bioabsorbable stents market. The report analyzes the bioabsorbable stent market by material, absorption rate, application, end user, and region
‧ Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and new product launches in the bioabsorbable stent market
‧ Competitive Assessment: In-depth assessment of market strategies, geographical and business segments, and product portfolios of the leading players in the bioabsorbable stent market
‧ Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for bioabsorbable stent market across geographies
‧ Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the bioabsorbable stent market

TABLE OF CONTENTS

1 INTRODUCTION 13
1.1 OBJECTIVES OF THE STUDY 13
1.2 MARKET DEFINITION 13
1.3 MARKET SCOPE 14
1.3.1 MARKETS COVERED 14
1.3.2 YEARS CONSIDERED FOR THE STUDY 15
1.4 CURRENCY 15
1.5 LIMITATIONS 15
1.6 MARKET STAKEHOLDERS 15
2 RESEARCH METHODOLOGY 16
2.1 MARKET SIZE ESTIMATION 17
2.2 MARKET BREAKDOWN AND DATA TRIANGULATION 20
2.3 KEY DATA FROM SECONDARY SOURCES 21
2.4 KEY DATA FROM PRIMARY SOURCES 22
2.5 ASSUMPTIONS FOR THE STUDY 22
3 EXECUTIVE SUMMARY 23
4 PREMIUM INSIGHTS 28
4.1 BIOABSORBABLE STENTS MARKET, BY MATERIAL 28
4.2 BIOABSORBABLE STENTS MARKET, BY ABSORPTION RATE 28
4.3 BIOABSORBABLE STENTS MARKET, BY END USER 29
4.4 BIOABSORBABLE STENTS MARKET, BY REGION 30
5 MARKET OVERVIEW 31
5.1 INTRODUCTION 32
5.2 MARKET DYNAMICS 32
5.2.1 DRIVERS 33
5.2.1.1 Rapidly growing aging population and increased risk of coronary artery disease and peripheral artery disease in the elderly 33
5.2.1.2 Strong product pipeline 34
5.2.2 RESTRAINTS 35
5.2.2.1 High device costs 35
5.2.3 OPPORTUNITIES 35
5.2.3.1 Emerging markets to offer high-growth opportunities for market players 35

5.2.4 CHALLENGES 36
5.2.4.1 Presence of substitutes 36
5.2.4.2 High risk of complications 36
6 REGULATORY SCENARIO 37
6.1 INTRODUCTION 37
6.2 FDA AND CE APPROVALS 37
6.3 PMA APPROVALS AND GOVERNMENT CERTIFICATES 38
7 BIOABSORBABLE STENTS MARKET, PIPELINE PRODUCTS 39
7.1 INTRODUCTION 39
7.2 PATENTS 39
8 BIOABSORBABLE STENTS MARKET, BY MATERIAL 41
8.1 INTRODUCTION 42
8.2 POLYMERIC STENTS 43
8.3 METALLIC STENTS 44
9 BIOABSORBABLE STENTS MARKET, BY ABSORPTION RATE 46
9.1 INTRODUCTION 47
9.2 SLOW-ABSORPTION STENTS 48
9.3 FAST-ABSORPTION STENTS 49
10 BIOABSORBABLE STENTS MARKET, BY DRUG 51
10.1 INTRODUCTION 52
10.2 PACLITAXEL 52
10.3 LIMUS-BASED DRUGS 53
11 BIOABSORBABLE STENTS MARKET, BY APPLICATION 55
11.1 INTRODUCTION 56
11.2 CORONARY ARTERY DISEASE 57
11.3 PERIPHERAL ARTERY DISEASE 58
12 BIOABSORBABLE STENTS MARKET, BY END USER 60
12.1 INTRODUCTION 61
12.2 HOSPITALS 62
12.3 CARDIAC CENTERS 63

13 BIOABSORBABLE STENTS MARKET, BY REGION 65
13.1 INTRODUCTION 66
13.2 NORTH AMERICA 67
13.2.1 U.S. 70
13.2.2 CANADA 72
13.3 EUROPE 74
13.3.1 GERMANY 78
13.3.2 FRANCE 80
13.3.3 U.K. 81
13.3.4 REST OF EUROPE (ROE) 83
13.4 ASIA 85
13.4.1 JAPAN 88
13.4.2 CHINA 90
13.4.3 INDIA 92
13.4.4 REST OF ASIA 94
13.5 REST OF THE WORLD 95
14 COMPETITIVE LANDSCAPE 98
14.1 OVERVIEW 98
14.2 MARKET SHARE ANALYSIS 99
14.3 COMPETITIVE SITUATIONS & TRENDS 100
14.3.1 NEW PRODUCT LAUNCHES & PRODUCT APPROVALS 101
14.3.2 AGREEMENTS 102
14.3.3 INVESTMENTS 102
15 COMPANY PROFILES 103
(Company at a Glance, Business Overview, Products Offered, Key Strategy, Recent Developments, SWOT Analysis & MNM View)*
15.1 INTRODUCTION 103
15.2 ABBOTT LABORATORIES 104
15.3 REVA MEDICAL, INC. 106
15.4 ELIXIR MEDICAL CORPORATION 107
15.5 KYOTO MEDICAL PLANNING CO., LTD. 108
15.6 AMARANTH MEDICAL, INC. 109
15.7 ARTERIAL REMODELING TECHNOLOGIES 110
15.8 BIOTRONIK 111
15.9 XENOGENICS CORPORATION (A SUBSIDIARY OF MULTICELL TECHNOLOGIES, INC.) 112
15.10 MERIL LIFE SCIENCES 113

15.11 SMT (PART OF SAHAJANAND GROUP OF COMPANIES) 114
15.12 TEPHA, INC. 115
15.13 ARTERIUS LIMITED 116
*Details on company at a glance, recent financials, Products offered, strategies & insights, & recent developments might not be captured in case of unlisted companies.
16 APPENDIX 117
16.1 INSIGHTS FROM INDUSTRY EXPERTS 117
16.2 DISCUSSION GUIDE 118
16.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 121
16.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 123
16.5 AVAILABLE CUSTOMIZATIONS 125
16.6 RELATED REPORTS 126